The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Pathology

• Publication date

  2009-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jcp.2009.066944PMID 19861558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of MAP 4 K 4 Is Associated withWorse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

  2008cited by this paper
• HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint

  2008cited by this paper
• Chromosomal instability in bladder cancer

  2008cited by this paper
• Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

  2008cited by this paper
• Overexpression of the Mitotic Checkpoint Genes BUB1 and BUBR1 is Associated with Genomic Complexity in Clear Cell Kidney Carcinomas

  2008cited by this paper
• Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.

  2008cited by this paper
• Molecular mechanisms of hepatocellular carcinoma

  2008cited by this paper
• Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure.

  2008cited by this paper
• Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.

  2008cited by this paper
• MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

  2008cited by this paper
• Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.

  2008cited by this paper
• p 53 Activation in Response to Mitotic Spindle Damage Requires Signaling via BubR 1-Mediated Phosphorylation

  2007cited by this paper
• p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.

  2007cited by this paper
• Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma.

  2007cited by this paper
• Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.

  2007cited by this paper
• International consensus on histologic diagnosis of early hepatocellular neoplasia

  2007cited by this paper
• Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma

  2007cited by this paper
• Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis

  2006cited by this paper
• Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinoma

  2006cited by this paper
• Transcriptional Control of BubR1 by p53 and Suppression of Centrosome Amplification by BubR1

  2005cited by this paper
• REporting recommendations for tumor MARKer prognostic studies (REMARK)

  2005cited by this paper
• On the road to cancer: aneuploidy and the mitotic checkpoint

  2005cited by this paper
• The human mitotic checkpoint protein BubR1 regulates chromosome–spindle attachments

  2005cited by this paper
• Aneuploidy and malignancy: an unsolved equation

  2004cited by this paper
• Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.

  2004cited by this paper
• Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma

  2004cited by this paper
• Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B

  2004cited by this paper
• Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability.

  2003cited by this paper
• Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1

  2003cited by this paper
• Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer—association with tumour cell proliferation

  2003cited by this paper
• The significance of unstable chromosomes in colorectal cancer

  2003cited by this paper
• Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1

  2002cited by this paper
• Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis

  2002cited by this paper
• The promoter region of the human BUBR1 gene and its expression analysis in lung cancer.

  2002cited by this paper
• Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma

  2002cited by this paper
• Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.

  2002cited by this paper
• Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Mitotic checkpoints: from yeast to cancer.

  2001cited by this paper
• Pathology and genetics of tumours of the digestive system

  2000cited by this paper

• The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach

  2024cites this paper
• BubR1 and SIRT2: Insights into Aneuploidy, Aging, and Cancer.

  2024cites this paper
• A Pan-Cancer Analysis of the Immunological and Prognostic Role of BUB1 Mitotic Checkpoint Serine/Threonine Kinase B (BUB1B) in Human Tumors.

  2024cites this paper
• BubR1 controls starvation-induced lipolysis via IMD signaling pathway in Drosophila

  2024cites this paper
• Overexpression of BubR1 Mitotic Checkpoint Protein Predicts Short Survival and Influences the Progression of Cholangiocarcinoma

  2024cites this paper
• Transcriptomics data mining to uncover signature genes in head and neck squamous cell carcinoma: a bioinformatics analysis and RNA-sequencing based validation.

  2023cites this paper
• BUBR1 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma

  2022cites this paper
• Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis

  2022cites this paper
• Studying the role of chromosomal instability (CIN) in GI cancers using patient-derived organoids.

  2021cites this paper
• Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis

  2021cites this paper
• Identification of Potential Biomarkers in Hepatocellular Carcinoma: A Network-Based Approach

  2020cites this paper
• Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis

  2020cites this paper
• Identification of potential key genes and pathways in hepatitis B virus-associated hepatocellular carcinoma by bioinformatics analyses

  2020cites this paper
• Identification of new candidate genes and signalling pathways associated with the development of neuroendocrine pancreatic tumours based on next generation sequencing data

  2020cites this paper
• Identification of Core Genes Related with Trophinin-Associated Protein (TROAP) Expression in Liver Cancer

  2020cites this paper
• Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer

  2020cites this paper
• Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis

  2020cites this paper
• Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma

  2020cites this paper
• Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma

  2019cites this paper
• The Anaphase Promoting Complex/Cyclosome (APC/C): A Versatile E3 Ubiquitin Ligase.

  2019cites this paper
• Defective mitosis-linked DNA damage response and chromosomal instability in liver cancer.

  2019cites this paper
• Exploring the molecular mechanism, biomarkers and prognostic values of HCC based on gene expression microarray

  2019cites this paper
• Co-expression Network Analysis Identifies Four Hub Genes Associated With Prognosis in Soft Tissue Sarcoma

  2019cites this paper
• Chromosomal instability-induced senescence potentiates cell non-autonomous tumourigenic effects

  2018cites this paper
• Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma

  2018cites this paper
• Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients

  2018cites this paper
• Aneuploidy: Cancer strength or vulnerability?

  2018cites this paper
• BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.

  2016cites this paper
• Predictive and prognostic values of BubR 1 and synuclein-gamma expression in breast cancer

  2015cites this paper
• Requirement for BUB1B/BUBR1 in tumor progression of lung adenocarcinoma

  2015cites this paper
• Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.

  2015cites this paper
• Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway.

  2015cites this paper
• Checkpoint mitótico como alvo terapêutico para sensibilizar células cancerígenas a agentes antimitóticos

  2015cites this paper
• Original Article Musashi-2 promotes hepatitis B virus related hepatocellular carcinoma progression via the Wnt/β-catenin pathway

  2015cites this paper
• Interferindo com o "checkpoint" mitótico para potenciar a ação de agentes anti-mitóticos

  2015cites this paper
• Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis.

  2014cites this paper
• TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis

  2014cites this paper
• As proteínas do checkpoint mitótico e o carcinoma oral de células escamosas: níveis de expressão e valor prognóstico

  2014cites this paper
• SiRNA‐targeted carboxypeptidase D inhibits hepatocellular carcinoma growth

  2013cites this paper
• Exploring CDC 20 gene expression in oral cavity cancer

  2013cites this paper
• New insights into the role of BubR1 in mitosis and beyond.

  2013cites this paper
• Increased expression of ZBP‐89 and its prognostic significance in hepatocellular carcinoma

  2012cites this paper
• Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.

  2012cites this paper
• BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival

  2011cites this paper
• Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.

  2011cites this paper
• Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.

  2011cites this paper
• BCR-ABL Hits at Mitosis; Implications for Chromosomal Instability, Aneuploidy and Therapeutic Strategy

  2011cites this paper
• Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication

  2011cites this paper
• Aneuploidy and tumorigenesis.

  2011cites this paper
• Deregulation of Anaphase-promoting Complex/cyclosome-dependent Proteolysis in Cancer

  2010cites this paper
• Oncotargets and Therapy Dovepress Dovepress Overexpression of Bub1b Contributes to Progression of Prostate Cancer and Predicts Poor Outcome in Patients with Prostate Cancer

  year unknowncites this paper